우울증의 진단 및 평가 지침 개발 : 평가 지침을 중심으로 = Development of Clinical Guideline for the Diagnosis and Evaluation of Depression : Focused on Evaluation Guideline

다국어 초록 (Multilingual Abstract)

ObjectivesZZThe aim of this study is to develop guideline for evaluation of depression.
MethodsZZDevelopment of this guideline was processed according to the ADAPTE manual,
which was developed for adaptation of good clinical practice guidelines. Important key questions
were determined, and a systematic review of clinical practice guidelines was performed. The
contents of guidelines selected by comparison of the methodological quality and currency were
evaluated with regard to the applicability and acceptability. Answers to key questions and clinical
recommendations were established by peer review.
ResultsZZCareful evaluations on the characteristics of depression, including subtype, severity,
suicidality, and psychiatric and physical comorbidities were recommended because these factors
can have an influence on course and prognosis in treatment of depression.
ConclusionZZThe results of this study may contribute to the systematic evaluation of depression,
based on clinical importance. However, this guideline did not include systematic reviews
regarding useful scales for evaluation of depression. In the future, amendment of this guideline
might be needed in order to supplement limitations

목차 (Table of Contents)

• 서 론
• 방 법
• 결 과
• 고 찰
• 결 론
• REFERENCES

참고문헌 (Reference)

1 조맹제, "한국 주요정신장애의 유병률 및 관련요인：2006 전국정신질환역학조사" 대한신경정신의학회 48 (48): 143-152, 2009

2 정지원, "주요우울증에서 자살경향성 : 공존질환의 영향" 대한신경정신의학회 51 (51): 85-92, 2012

3 Chen L, "Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors:a longitudinal, population-based study" 59 : 1-11, 2000

4 Hall RC, "Thyroid disease and abnormal thyroid function tests in women with eating disorders and depression" 82 : 187-192, 1995

5 van der Lem R, "The generalizability of antidepressant efficacy trials to routine psychiatric outpatient practice" 41 : 1353-1363, 2011

6 McIntyre RS, "The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders" 24 : 69-81, 2012

7 Ros LT, "Symptomatic depression after long-term steroid treatment: a case report" 33 : 263-265, 2004

8 Isometsä ET, "Suicide in major depression" 151 : 530-536, 1994

9 Davis LL, "Substance use disorder comorbidity in major depressive disorder:a confirmatory analysis of the STAR*D cohort" 15 : 278-285, 2006

10 Khan A, "Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database" 22 : 40-45, 2002

11 Yang SJ, "Response to antidepressants in major depressive disorder with melancholic features: the CRESCEND study" 144 : 42-50, 2013

12 Farabaugh A, "Relationships between major depressive disorder and comorbid anxiety and personality disorders" 46 : 266-271, 2005

13 Kim SW, "Relationship between a history of a suicide attempt and treatment outcomes in patients with depression" 31 : 449-456, 2011

14 Mueller TI, "Prognostic effect of the variable course of alcoholism on the 10-year course of depression" 151 : 701-706, 1994

15 Beautrais AL, "Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study" 153 : 1009-1014, 1996

16 Hirschfeld RM, "Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine" 59 : 669-675, 1998

17 Kim JM, "Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study" 26 : 41-50, 2011

18 American Psychiatric Association, "Practice Guideline for the Treatment of Patients With Major Depressive Disorder" American Psychiatric Association 2010

19 Kim JM, "Physical comorbidity and 12-week treatment outcomes in Korean patients with depressive disorders: the CRESCEND study" 71 : 311-318, 2011

20 Uher R, "Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline" 132 : 112-120, 2011

21 Morris DW, "Measurement-based care for unipolar depression" 13 : 446-458, 2011

22 Kim SY, "Manual for Guideline Adaptation Ver 2.0" National Evidencebased Healthcare Collaborating Agency 2011

23 Fraguas R Jr, "Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study" 48 : 418-425, 2007

24 Brådvik L, "Long-term suicide risk of depression in the Lundby cohort 1947-1997--severity and gender" 117 : 185-191, 2008

25 Jeon HJ, "Lifetime prevalence and correlates of suicidal ideation, plan, and single and multiple attempts in a Korean nationwide study" 198 : 643-646, 2010

26 ICSI Health Care Guideline Working Group, "Institude for Clinical System Improvement (ICSI) Health Care Guideline: Major Depression in Adults in Primary Care" Institute for Clinical Systems Improvement, Inc 2011

27 Elkin I, "Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program" 63 : 841-847, 1995

28 New Zealand Guidelines Group, "Identification of Common Mental Disorders and Management of Depression in Primary Care. An Evidence-based Best Practice Guideline"

29 Merikangas KR, "Heterogeneity of depression. Classification of depressive subtypes by longitudinal course" 164 : 342-348, 1994

30 Egede LE, "Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes" 67 : 46-51, 2005

31 Seo HJ, "Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression" 199 : 42-48, 2011

32 Schmitt AB, "Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity" 259 : 329-339, 2009

33 Fava M, "Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report" 165 : 342-351, 2008

34 Terao T., "Diagnosis and severity assessment of patients with depression" 65 : 1614-1618, 2007

35 National Institute for Health and Clinical Excellence, "Depression: the Treatment and Management of Depression in Adults" National Institute for Health and Clinical Excellence 2009

36 Roy A., "Depression, attempted suicide, and suicide in patients with chronic schizophrenia" 9 : 193-206, 1986

37 Lichtman JH, "Depression and coronary heart disease:recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association" 118 : 1768-1775, 2008

38 Austin MP, "Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?" 29 : 73-85, 1999

39 Pagliaro LA, "Cocaine use and depression" 147 : 1636-1637, 1992

40 Schotte CK, "Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes" 71 : 181-195, 1997

41 Yates WR, "Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis" 9 : 7-15, 2007

42 Claassen CA, "Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial" 97 : 77-84, 2007

43 Park MH, "Clinical characteristics of depressed patients with a history of suicide attempts:results from the CRESCEND study in South Korea" 198 : 748-754, 2010

44 Kennedy SH, "Canadian Network for Mood and Anxiety Treatments (CANMAT)Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies" 117 (117): S44-S53, 2009

45 Kennedy SH, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction" 117 (117): S1-S2, 2009

46 Friedman ES, "Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial" 22 : 183-199, 2012

47 Kozhimannil KB, "Association between diabetes and perinatal depression among low-income mothers" 301 : 842-847, 2009

48 Jiang W, "Antidepressant therapy in patients with ischemic heart disease" 150 : 871-881, 2005

49 Bostwick JM, "Affective disorders and suicide risk: a reexamination" 157 : 1925-1932, 2000

50 Dorpat TL, "A study of suicide in the Seattle area" 1 : 349-359, 1960